首页> 外文期刊>Biological psychiatry >Toll-like receptor 4 regulates chronic stress-induced visceral pain in mice
【24h】

Toll-like receptor 4 regulates chronic stress-induced visceral pain in mice

机译:Toll样受体4调节小鼠慢性应激引起的内脏痛

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background Functional gastrointestinal disorders, which have visceral hypersensitivity as a core symptom, are frequently comorbid with stress-related psychiatric disorders. Increasing evidence points to a key role for toll-like receptor 4 (TLR4) in chronic pain states of somatic origin. However, the central contribution of TLR4 in visceral pain sensation remains elusive. Methods With pharmacological and genetic approaches, we investigated the involvement of TLR4 in the modulation of visceral pain. The TLR4-deficient and wild-type mice were exposed to chronic stress. Visceral pain was evaluated with colorectal distension. Protein expression levels for TLR4, Cd11b, and glial fibrillary acidic protein (glial cells markers) were quantified in the lumbar region of the spinal cord, prefrontal cortex (PFC), and hippocampus. To evaluate the effect of blocking TLR4 on visceral nociception, TAK-242, a selective TLR4 antagonist, was administered peripherally (intravenous) and centrally (intracerebroventricular and intra-PFC) (n = 10-12/experimental group). Results The TLR4 deficiency reduced visceral pain and prevented the development of chronic psychosocial stress-induced visceral hypersensitivity. Increased expression of TLR4 coupled with enhanced glia activation in the PFC and increased levels of proinflammatory cytokines were observed after chronic stress in wild-type mice. Administration of a TLR4 specific antagonist, TAK-242, attenuated visceral pain sensation in animals with functional TLR4 when administrated centrally and peripherally. Moreover, intra-PFC TAK-242 administration also counteracted chronic stress-induced visceral hypersensitivity. Conclusions Our results reveal a novel role for TLR4 within the PFC in the modulation of visceral nociception and point to TLR4 as a potential therapeutic target for the development of drugs to treat visceral hypersensitivity.
机译:背景技术以内脏超敏为核心症状的功能性胃肠疾病通常与压力相关的精神疾病并存。越来越多的证据表明,toll​​样受体4(TLR4)在体源性慢性疼痛状态中起着关键作用。但是,TLR4在内脏疼痛感方面的主要作用仍然难以捉摸。方法采用药理和遗传学方法,我们调查了TLR4在调节内脏痛中的作用。 TLR4缺陷和野生型小鼠暴露于慢性应激。用大肠扩张评估内脏疼痛。在脊髓,前额叶皮层(PFC)和海马区的腰部区域定量测定TLR4,Cd11b和神经胶质纤维酸性蛋白(胶质细胞标志物)的蛋白表达水平。为了评估阻断TLR4对内脏伤害感受的作用,在外周(静脉)和中央(脑室内和PFC内)(n = 10-12 /实验组)给予TAK-242,一种选择性的TLR4拮抗剂。结果TLR4缺乏症减轻了内脏疼痛,并防止了慢性心理应激引起的内脏超敏反应的发展。在野生型小鼠慢性应激后,观察到PLR中TLR4表达增加,胶质细胞活化增强,促炎细胞因子水平升高。 TLR4特异性拮抗剂TAK-242的使用,在中央和周围给药时,可减轻具有功能性TLR4的动物的内脏疼痛感。此外,PFC TAK-242内给药也抵消了慢性应激引起的内脏超敏反应。结论我们的研究结果揭示了PFC中TLR4在调节内脏伤害感受中的新作用,并指出TLR4作为开发治疗内脏超敏反应药物的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号